U.S. Issues Public Health Emergency About Swine Flu
More News related to ALNY
- Alnylam Presents New Pre-clinical Data on ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancer
- Alnylam Pharma (ALNY) To Provide RNAi Pipeline, Platform, and Tech Update at R&D Day in NY
- Alnylam Provides Update on RNAi Pipeline, Platform, and Technology at Its R&D Day
- Alnylam to Webcast R&D Day on Thursday, November 12, 2009
- Alnylam Presents New Pre-Clinical Data on RNAi Therapeutics at Oligonucleotides Therapeutics Society (OTS) Meeting
More News related to AVII
- AVI BioPharma (AVII) to Present Data for Duchenne Muscular Dystrophy Therapy at TREAT-NMD/NIH Conference
- AVI BioPharma, Inc. Presents Update on AVI-4658 at TREAT-NMD / NIH International Conference
- AVI BioPharma, Inc. to Present at Transformational Medical Technologies Initiative (TMTI) Industry Day
- AVI BioPharma (AVII) Misses Q3 Views by 1c
- AVI BioPharma Announces Third Quarter 2009 Financial Results & Corporate Highlights
More News related to BCRX
- BioCryst Pharma (BCRX) Priced 5M Common Offering at $9.75/Share
- BioCryst Announces Pricing of Public Offering of Common Stock
- Momentum Mover BioCryst (BCRX) Down On Stock Offering
- BioCryst Pharma (BCRX) Files 5M Common Stock Shelf
- BioCryst Announces Proposed Public Offering of Common Stock
More News related to Hot List
- Campbell Soup (CPB) Reports Mixed Q1 Results; Raises FY10 Outlook
- Peet's Coffee (PEET) boosts Diedrich Coffee (DDRX) purchase offer to $32/share
- Diedrich Coffee (DDRX) halted with news pending
- Cephalon (CEPH) trading halted with news pending
- LDK Solar (LDK) Tops Q3 EPS by 37c, Guides Sales Well Above the Street
On Sunday, the U.S. Department of Health and Human Service issued a nationwide public health emergency about the swine flu after outbreaks around the world and here in the U.S.
To date, there have been 20 confirmed cases of swine flu in California, Texas, Kansas, New York, and Ohio. No deaths in the U.S. have been reported due to the illness. Additional cases of the virus have been confirmed in Mexico and Canada. In Mexico, swine flu is the suspected cause of 86 deaths and more than 1,300 illnesses.
Swine flu is a respiratory disease of pigs caused by type A influenza that regularly causes outbreaks of influenza among pigs. Swine flu viruses do not normally infect humans; however, human infections with swine flu do occur, and cases of human-to-human spread of swine flu viruses have been documented.
According to reports, although swine flu vaccines are thought to be inadequate, Gilead Sciences' (Nasdaq: GILD) and Roche's Tamiflu and Biota's Relenza, licensed to GlaxoSmithKline (NYSE: GSK), is having a positive response against the illness said the World Health Organization.
Stock traders would have to expect that the pandemic potential of the swine flu outbreak could drive other speculative stocks higher. Here is a list of stocks that were running with the bird flu outbreaks a few years ago. It could be a good place to start looking: BioCryst Pharmaceuticals (NASDAQ: BCRX), Novavax Inc. (NASDAQ: NVAX), AVI Biopharma Inc. (Nasdaq: AVII), Crucell NV (Nasdaq: CRXL), Hemispherx Biopharma, Inc. (AMEX: HEB), Quidel Corporation (Nasdaq: QDEL), Generex Biotechnology Corporation (Nasdaq: GNBT), Peregrine Pharmaceuticals (Nasdaq: PPHM), Combimatrix (Nasdaq: CBMX), Quigley Corp. (Nasdaq: QGLY), Celldex (Nasdaq: CLDX), Luminex Corporation (Nasdaq: LMNX), CEL-SCI Corp. (AMEX: CVM), Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY), Vical (Nasdaq: VICL).
Related Categories
Hot ListInsiders' Blog
Momentum Movers
Trader Talk
Stocks Mentioned
+0.14
-0.44Comments
i see what you mean
that stock finished up over 18% for the day on big volume. that's a much bigger gain than most of those stocks mentioned by hot list - and it was much higher earlier in the day. http://cxa.marketwatch.com/tsx/en/market/quote.aspx?symbol=rbm
3M Rapid Detection Flu A+B Test
I am surprised that this article didn't mention Response Biomedical (TSX: RBM), which makes the rapid flu test marketed by 3M as the 3M Rapid Detection Flu A + B Test. It was just launched in the fall and is a more accurate and sophisticated test than the other point of care tests on the market, like Quidel. By the way, RBM is also partnered with Roche (maker of Tamiflu) in an agreement to supply all of Roche's point of care cardiology tests and Cardiac Readers, which just launched in March of April.
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
money makers that will save- prolong life
Tony C on Apr 28, 2009 09:13 AMprovectus pharma pvct another cancer cure +++ dandrion DNDN jump on board